2 April 2021 in Proceedings of the National Academy of Sciences
One third of the western population suffers from nonalcoholic fatty liver disease (NAFLD), which may ultimately develop into hepatocellular carcinoma (HCC). The molecular event(s) that triggers the disease are not clear. Current understanding, known as the multiple hits model, suggests that NAFLD is a result of diverse events at several tissues (e.g., liver, adipose tissues, and intestine) combined with changes in metabolism and microbiome. In contrast to this prevailing concept, we report that fatty liver could be triggered by a single mutated protein expressed only in the liver. We established a transgenic system that allows temporally controlled activation of the MAP kinase p38α in a tissue-specific manner by induced expression of intrinsically active p38α allele. Here we checked the effect of exclusive activation in the liver. Unexpectedly, induction of p38α alone was sufficient to cause macrovesicular fatty liver. Animals did not become overweight, showing that fatty liver can be imposed solely by a genetic modification in liver per se and can be separated from obesity. Active p38α-induced fatty liver is associated with up-regulation of MUC13, CIDEA, PPARγ, ATF3, and c-jun mRNAs, which are up-regulated in human HCC. Shutting off expression of the p38α mutant resulted in reversal of symptoms. The findings suggest that p38α plays a direct causative role in fatty liver diseases and perhaps in other chronic inflammatory diseases. As p38α activity was induced by point mutations, it could be considered a proto-inflammatory gene (proto-inflammagene). Significance While the MAPK p38α is highly active in nonalcoholic fatty liver disease (NAFLD), whether its constitutive activity is a driver or mere consequence of pathology remains unclear. This was not answered due to the lack of methods for specific p38α activation in vivo. A transgenic mouse model allowing inducible expression of an intrinsically active p38α variant in a tissue-specific manner meets this challenge. Upon expression of the active p38α allele in the liver, mice develop lipidosis (fatty liver) within four weeks without gaining overweight. This study shows that fatty liver could occur in response to activation of a single protein and provides the first genetic model for revealing the etiology of fatty liver diseases from the point of their trigger.